Dr. McCullers, Infectious Disease Specialist, UTHSC, answers COVID-19 vaccine questions
Dr. McCullers, Infectious Disease Specialist, UTHSC, answers COVID-19 vaccine questions December 19: WMC Action News 5
Publisher: WMC
Vaccine Q&A: Le Bonheur infection prevention director discusses Tennessee’s vaccine rollout
Doctor Nick Hysmith, medical director of infection prevention at Le Bonheur Children’s Hospital, spoke with WMC Action News 5′s Joe Birch Tuesday about the COVID-19 vaccine rollout in Tennessee. Hysmith also serves on the Methodist Le Bonheur Vaccine Task Force and is a professor at the University of Tennessee Health Sciences Center.
UTHSC and Regional One team up to help ‘long haulers’ with symptoms long after surviving COVID-19
The University of Tennessee Health Science Center is partnering with Regional One Health to offer a post-COVID-19 clinic to help people suffering with sometimes debilitating symptoms weeks and even months after their COVID-19 diagnosis. • December 15: WMC Action News 5 at 5:00PM • December 16: WMC Action News 5 at 4:30 AM • December… Read More
UTHSC official shares unique history with retired general Lloyd Austin
An official at the University of Tennessee Health Science Center has a unique history with Retired Army General Lloyd Austin. Love Collins III is the vice-chancellor of Development and Alumni Affairs for the University of Tennessee Health Science Center. He was track teammates with Austin at West Point in the mid-70s. They’ve known each other… Read More
St. Jude, UTHSC need 500 participants in COVID-19 vaccine clinical trial
St. Jude and UTHSC have started recruiting adults ages 18 and older, in the Memphis area, for phase 3 of a clinical research study to evaluate a possible COVID-19 vaccine. December 4: WMC Action News AM at 5:30AM December 4: WMC Action News AM at 6AM December 4: WLBT 6:30AM News December 3: WMC Action… Read More
Multiple COVID-19 vaccine/treatment trials underway in Memphis
St. Jude announced Friday they’re looking for 500 adult participants in a phase three clinical trial of a COVID-19 vaccine. Multiple trials for vaccines and therapies are underway in Memphis right now. St. Jude said a phase three clinical trial of a COVID-19 vaccine with Johnson & Johnson will take place on their campus. Participants… Read More
St. Jude, UTHSC looking for local participants in phase 3 of COVID-19 vaccine trial
Mid-South leaders in the medical community are searching for participants for the next phase of the COVID-19 vaccine trial. St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are offering a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ENSEMBLE trial.
St. Jude, UTHSC looking for local participants in phase 3 of COVID-19 vaccine trial
Mid-South leaders in the medical community are searching for participants for the next phase of the COVID-19 vaccine trial. St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are offering a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ensemble trial, according to… Read More